EWA
BPMC

EverSource Wealth Advisors’s Blueprint Medicines BPMC Stock Holding History

EverSource Wealth Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-315
Closed -$40.4K – 4336
2025
Q2 		$40.4K Buy
315
+125
+66% +$13K ﹤0.01% 1763
2025
Q1 		$16.8K Buy
190
+28
+17% +$2.73K ﹤0.01% 1795
2024
Q4 		$14.1K Buy
162
+134
+479% +$12.3K ﹤0.01% 1821
2024
Q3 		$2.59K Sell
28
-1
-3% -$99 ﹤0.01% 2453
2024
Q2 		$3.14K Buy
29
+8
+38% +$801 ﹤0.01% 2395
2024
Q1 		$1.92K Hold
21
– – ﹤0.01% 2400
2023
Q4 		$1.94K Hold
21
– – ﹤0.01% 2177
2023
Q3 		$1.05K Buy
+21
New +$1.12K ﹤0.01% 2184
2022
Q2 		– Sell
-81
Closed -$5K – 1724
2022
Q1 		$5K Hold
81
– – ﹤0.01% 1223
2021
Q4 		$9K Buy
+81
New +$8.47K ﹤0.01% 990

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

EverSource Wealth Advisors's BPMC Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 315 shares — an estimated $40.4K sold.

EverSource Wealth Advisors first reported a position in BPMC in Q4 2021 and held it in 10 quarters. The position peaked at $40.4K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • EverSource Wealth Advisors reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 315 Blueprint Medicines shares in Q3 2025, an estimated $40.4K.
  • EverSource Wealth Advisors first reported a position in Blueprint Medicines in Q4 2021 and held it in 10 quarters.
  • EverSource Wealth Advisors's Blueprint Medicines position peaked at $40.4K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.